Scotiabank Maintains Sector Outperform on Vera Therapeutics, Raises Price Target to $65

Benzinga · 06/02/2025 17:41
Scotiabank analyst Greg Harrison maintains Vera Therapeutics (NASDAQ:VERA) with a Sector Outperform and raises the price target from $55 to $65.